Educational use only — not investment advice. "Undervalued / fairly valued / overvalued" and every risk score reflect our models vs. price, which can be wrong or based on stale or incomplete data. Always review the company's own financials and SEC filings, and consult a licensed advisor, before acting.
MTUS
Fairly valued
Metallus Inc.
Price$19.99
Model IV$19.93
P/IV0.99
Premium +0%
Return to IV: -0.3%
Market implies -2.9%/yr
vs model +0.0% · in line
MTW
Deeply undervalued
MANITOWOC CO INC
Price$21.67
Model IV$46.40
P/IV0.26
Discount 53%
Return to IV: +114.1%
Market implies -11.7%/yr
vs model +6.8% · below model
MUJ
Valuation N/A
BLACKROCK MUNIHOLDINGS NEW JERSEY QUALITY FUND, INC.
Price$11.26
Model IV—
P/IV—
Limited data — see page
MUX
Valuation N/A
McEwen Inc.
Price$17.88
Model IV—
P/IV—
Market implies +90.5%/yr
vs model +6.4% · above model
MVBF
Deeply overvalued
MVB FINANCIAL CORP
Price$28.91
Model IV$22.20
P/IV1.21
Premium +30%
Return to IV: -23.2%
MVST
Deeply undervalued
Microvast Holdings, Inc.
Price$0.58
Model IV$3.33
P/IV0.47
Discount 83%
Return to IV: +475.4%
Market implies -11.7%/yr
vs model +24.3% · below model
MX
Valuation N/A
MAGNACHIP SEMICONDUCTOR Corp
Price$3.12
Model IV—
P/IV—
Market implies +20.5%/yr
vs model +2.0% · above model
MYE
Overvalued
MYERS INDUSTRIES INC
Price$30.63
Model IV$23.61
P/IV1.35
Premium +30%
Return to IV: -22.9%
Market implies +7.8%/yr
vs model +6.2% · in line
MYGN
Deeply undervalued
MYRIAD GENETICS INC
Price$4.31
Model IV$9.25
P/IV0.43
Discount 53%
Return to IV: +114.7%
Market implies -12.5%/yr
vs model +4.5% · below model
NABL
Deeply overvalued
N-able, Inc.
Price$4.63
Model IV$2.88
P/IV1.44
Premium +61%
Return to IV: -37.7%
Market implies +15.0%/yr
vs model +11.4% · above model
NAGE
Deeply overvalued
Niagen Bioscience, Inc.
Price$2.69
Model IV$1.72
P/IV2.24
Premium +56%
Return to IV: -36.0%
Market implies +17.4%/yr
vs model +15.4% · in line
NAK
Valuation N/A
NORTHERN DYNASTY MINERALS LTD
Price$1.12
Model IV—
P/IV—
Market implies +44.1%/yr
vs model +5.0% · above model
NAMI
Valuation N/A
Jinxin Technology Holding Co
Price$2.19
Model IV—
P/IV—
Market implies +42.4%/yr
vs model +15.0% · above model
NAMSW
Valuation N/A
NewAmsterdam Pharma Co N.V.
Price$11.00
Model IV—
P/IV—
Market implies +41.5%/yr
NAT
Deeply overvalued
NORDIC AMERICAN TANKERS Ltd
Price$8.47
Model IV$2.87
P/IV1.79
Premium +195%
Return to IV: -66.1%
Market implies +20.5%/yr
vs model +9.6% · above model
NATH
Deeply overvalued
NATHANS FAMOUS, INC.
Price$101.77
Model IV$69.18
P/IV1.36
Premium +47%
Return to IV: -32.0%
Market implies +11.3%/yr
vs model +8.3% · in line
NATR
Deeply undervalued
NATURES SUNSHINE PRODUCTS INC
Price$12.64
Model IV$34.14
P/IV0.62
Discount 63%
Return to IV: +170.1%
Market implies -7.5%/yr
vs model +6.8% · below model
NAUT
Valuation N/A
Nautilus Biotechnology, Inc.
Price$2.25
Model IV—
P/IV—
Limited data — see page
NAVI
Deeply undervalued
NAVIENT CORP
Price$9.11
Model IV$28.51
P/IV0.30
Discount 68%
Return to IV: +213.0%
Market implies -27.7%/yr
vs model -6.8% · below model
NAVN
Fairly valued
Navan, Inc.
Price$23.64
Model IV$24.27
P/IV0.81
Discount 3%
Return to IV: +2.7%
Market implies -0.3%/yr
vs model +32.1% · below model
NB
Valuation N/A
NIOCORP DEVELOPMENTS LTD
Price$3.37
Model IV—
P/IV—
Market implies +60.4%/yr
vs model +5.0% · above model
NBBK
Overvalued
NB Bancorp, Inc.
Price$22.12
Model IV$17.49
P/IV1.15
Premium +26%
Return to IV: -20.9%
NBHC
Fairly valued
National Bank Holdings Corp
Price$37.93
Model IV$34.59
P/IV1.15
Premium +10%
Return to IV: -8.8%
NBP
Valuation N/A
NovaBridge Biosciences
Price$1.40
Model IV—
P/IV—
Market implies +86.4%/yr
vs model +15.0% · above model
NBR
Deeply undervalued
NABORS INDUSTRIES LTD
Price$80.67
Model IV$119.37
P/IV0.70
Discount 32%
Return to IV: +48.0%
Market implies -2.4%/yr
vs model +5.4% · below model
NBTX
Valuation N/A
Nanobiotix S.A.
Price$23.68
Model IV—
P/IV—
Market implies +150.0%/yr
NC
Undervalued
NACCO INDUSTRIES INC
Price$35.57
Model IV$49.16
P/IV1.03
Discount 28%
Return to IV: +38.2%
Market implies +1.0%/yr
vs model +8.0% · below model
NCDL
Deeply undervalued
Nuveen Churchill Direct Lending Corp.
Price$10.81
Model IV$99.54
P/IV0.13
Discount 89%
Return to IV: +820.8%
Market implies -24.1%/yr
vs model +10.0% · below model
NCNO
Fairly valued
nCino, Inc.
Price$19.73
Model IV$19.38
P/IV0.83
Premium +2%
Return to IV: -1.8%
Market implies -1.9%/yr
vs model +21.4% · below model
NCV
Valuation N/A
Virtus Convertible & Income Fund
Price$15.67
Model IV—
P/IV—
Limited data — see page
NCZ
Valuation N/A
Virtus Convertible & Income Fund II
Price$14.51
Model IV—
P/IV—
Limited data — see page
NECB
Undervalued
NorthEast Community Bancorp, Inc./MD/
Price$27.00
Model IV$33.97
P/IV0.71
Discount 21%
Return to IV: +25.8%
NEGG
Valuation N/A
Newegg Commerce, Inc.
Price$11.58
Model IV—
P/IV—
Market implies +98.4%/yr
NEWP
Valuation N/A
NEW PACIFIC METALS CORP
Price$6.58
Model IV—
P/IV—
Market implies +71.5%/yr
vs model +5.0% · above model
NEWT
Deeply undervalued
NewtekOne, Inc.
Price$10.89
Model IV$22.10
P/IV0.51
Discount 51%
Return to IV: +102.9%
NEWTG
Fairly valued
NewtekOne, Inc.
Price$24.71
Model IV$28.38
P/IV0.88
Discount 13%
Return to IV: +14.9%
NEWTH
Fairly valued
NewtekOne, Inc.
Price$25.11
Model IV$28.38
P/IV0.89
Discount 12%
Return to IV: +13.0%
NEWTI
Fairly valued
NewtekOne, Inc.
Price$24.74
Model IV$28.38
P/IV0.89
Discount 13%
Return to IV: +14.7%
NEWTO
Fairly valued
NewtekOne, Inc.
Price$25.01
Model IV$22.86
P/IV1.14
Premium +9%
Return to IV: -8.6%
NEWTP
Fairly valued
NewtekOne, Inc.
Price$24.25
Model IV$26.17
P/IV0.95
Discount 7%
Return to IV: +7.9%
NEXN
Valuation N/A
Nexxen International Ltd.
Price$8.95
Model IV—
P/IV—
Limited data — see page
NFBK
Overvalued
Northfield Bancorp, Inc.
Price$15.31
Model IV$12.57
P/IV1.13
Premium +22%
Return to IV: -17.9%
NFGC
Valuation N/A
New Found Gold Corp.
Price$1.57
Model IV—
P/IV—
Market implies +45.3%/yr
vs model +5.0% · above model
NGNE
Valuation N/A
Neurogene Inc.
Price$26.40
Model IV—
P/IV—
Market implies +99.0%/yr
vs model +15.0% · above model
NGS
Deeply overvalued
NATURAL GAS SERVICES GROUP INC
Price$33.10
Model IV$14.71
P/IV2.67
Premium +125%
Return to IV: -55.6%
Market implies +13.1%/yr
vs model +4.0% · above model
NGVC
Deeply overvalued
Natural Grocers by Vitamin Cottage, Inc.
Price$29.68
Model IV$22.47
P/IV1.32
Premium +32%
Return to IV: -24.3%
Market implies +7.1%/yr
vs model +5.3% · in line
NHP
Deeply overvalued
National Healthcare Properties, Inc.
Price$15.55
Model IV$5.20
P/IV2.78
Premium +199%
Return to IV: -66.6%
NHPAP
Deeply overvalued
National Healthcare Properties, Inc.
Price$25.24
Model IV$12.15
P/IV1.84
Premium +108%
Return to IV: -51.9%
NHPBP
Deeply overvalued
National Healthcare Properties, Inc.
Price$25.44
Model IV$7.73
P/IV3.28
Premium +229%
Return to IV: -69.6%
NIU
Valuation N/A
Niu Technologies
Price$1.97
Model IV—
P/IV—
Market implies +27.6%/yr
vs model +3.4% · above model
NKLR
Valuation N/A
Terra Innovatum Global N.V.
Price$3.16
Model IV—
P/IV—
Limited data — see page
NL
Deeply overvalued
NLI HOLDINGS, INC.
Price$6.94
Model IV$4.57
P/IV1.52
Premium +52%
Return to IV: -34.2%
Market implies +8.7%/yr
vs model +4.4% · above model
NMAX
Valuation N/A
Newsmax Inc.
Price$10.34
Model IV—
P/IV—
Market implies +22.0%/yr
NMCO
Valuation N/A
Nuveen Municipal Credit Opportunities Fund
Price$8.70
Model IV—
P/IV—
Limited data — see page
NMFC
Deeply undervalued
New Mountain Finance Corp
Price$6.73
Model IV$43.88
P/IV0.18
Discount 85%
Return to IV: +552.0%
Market implies -21.8%/yr
vs model +6.0% · below model
NMG
Valuation N/A
Nouveau Monde Graphite Inc.
Price$1.05
Model IV—
P/IV—
Limited data — see page
NMM
Deeply undervalued
Navios Maritime Partners L.P.
Price$93.06
Model IV$549.77
P/IV0.13
Discount 83%
Return to IV: +490.8%
Market implies -13.9%/yr
vs model +13.8% · below model
NMRA
Valuation N/A
Neumora Therapeutics, Inc.
Price$0.48
Model IV—
P/IV—
Limited data — see page
NNAVW
Valuation N/A
NNAVW
Price$5.50
Model IV—
P/IV—
Limited data — see page
NNBR
Fairly valued
NN INC
Price$3.95
Model IV$3.63
P/IV1.06
Premium +9%
Return to IV: -8.2%
Market implies +4.2%/yr
vs model +2.0% · in line